Condition
Pseudoexfoliation Glaucoma in Both Eyes
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed2
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06993311Completed
Real World Evidence of Xen45 Gel Implant in Pseudoexfoliation Glaucoma
NCT05113121Completed
Correlation Between Pupil Size and Ocular Signs of Pseudoexfoliation Syndrome
NCT04202510Not ApplicableWithdrawn
IOP and Medication Reduction in MIGS Procedures
Showing all 3 trials